Dr. William Marcus Newberry, MD

Dr. Newberry practices at St. Luke's Boise Medical Center in Boise, Idaho, part of St. Luke's Health System.

Dr. Newberry's NPI, 1629148762, was assigned on November 8, 2006. Dr. Newberry graduated from Medical University of South Carolina College of Medicine in 1992. Dr. Newberry holds Oregon license MD213839.

Dr. Newberry's primary practice is St. Luke's Boise Medical Center, at 190 East Bannock Street, Boise, ID 83712 in Ada County. The practice phone is (208) 381-2222.

Dr. Newberry's primary practice is St. Luke's Boise Medical Center in Boise, Idaho, part of St. Luke's Health System. Dr. Newberry is also affiliated with St. Charles Bend. The medical group on file is St. Luke's Health System. Dmand AI also links Dr. Newberry to 3 more hospitals, 2 group practices and clinics, 2 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Newberry practices, 8 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Newberry's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Newberry's licenses on file in 2 states: Oregon and South Carolina.

CMS data shows 32,763 Medicare services from Dr. Newberry across 41 procedure codes in 2024, for 489 Medicare patients. Medicare paid $683,239 for them. Every service was in an office.

CMS counts 489 Medicare patients who saw Dr. Newberry in 2024. The largest group is 65 to 74, with 224 patients. 73% of them have high cholesterol, and 67% have high blood pressure. 7% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Newberry's median patient age at 72, with 50% women.

In 2024, Dr. Newberry wrote 907 Medicare Part D claims for 209 patients. 85% of them were for generic drugs. CMS names the drug for 727 of them, across 22 drugs with 11 or more claims each, at $1,185,182 in total drug cost. In 2023, CMS named 585 claims across 15 drugs.

Dr. Newberry accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Newberry as offering telehealth.

Dmand AI links Dr. Newberry to 4 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Rectal Diseases and Thyroid Neoplasms. Alliance for Clinical Trials in Oncology sponsors the most, 2.

CMS Open Payments shows 12 general payments to Dr. Newberry from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Gilead Sciences, Inc. paid the most, $55.

Dr. Newberry graduated from Medical University of South Carolina College of Medicine in 1992.